Un medicamento que interrumpe la producción de leche materna reduce el riesgo de cáncer de mama, según un estudio español

A Spanish study has identified that cabergoline, a medication traditionally used to inhibit breast milk production, may reduce the risk of postpartum breast cancer. The drug, which is administered in a single dose, has been utilized for decades to manage lactation and is now being investigated as a potential preventative treatment for breast cancer following childbirth.